Updated Jul 16, 2026
Lehman David Aaron has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $122K.
David Aaron Lehman is the General Counsel at Pulmonx Corp, a medical technology company specializing in treatments for severe emphysema. He has been involved in the company's legal affairs, contributing to its operations in the healthcare sector.
| Role | Insider |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-03 | LUNG | Pulmonx Corp | S — Open-market sale | 4.9K | $1.54 | $8K |
| 2026-06-03 | LUNG | Pulmonx Corp | S — Open-market sale | 3.5K | $1.54 | $5K |
| 2026-06-03 | LUNG | Pulmonx Corp | S — Open-market sale | 2.3K | $1.54 | $3K |
| 2026-06-03 | LUNG | Pulmonx Corp | S — Open-market sale | 3.9K | $1.54 | $6K |
| 2026-03-05 | LUNG | Pulmonx Corp | A — Grant or award | 150.0K | $0.00 | |
| 2026-03-05 | LUNG | Pulmonx Corp | S — Open-market sale | 4.1K | $1.43 | $6K |
| 2026-03-05 | LUNG | Pulmonx Corp | S — Open-market sale | 2.6K | $1.43 | $4K |
| 2026-03-05 | LUNG | Pulmonx Corp | S — Open-market sale | 4.4K | $1.43 | $6K |
| 2026-03-05 | LUNG | Pulmonx Corp | S — Open-market sale | 1.2K | $1.43 | $2K |
| 2025-09-02 | LUNG | Pulmonx Corp | S — Open-market sale | 3.2K | $1.60 | $5K |
| 2025-09-02 | LUNG | Pulmonx Corp | S — Open-market sale | 2.1K | $1.60 | $3K |
| 2025-09-02 | LUNG | Pulmonx Corp | S — Open-market sale | 3.5K | $1.60 | $6K |
| 2025-09-02 | LUNG | Pulmonx Corp | S — Open-market sale | 929 | $1.60 | $1K |
| 2025-06-02 | LUNG | Pulmonx Corp | S — Open-market sale | 3.3K | $3.13 | $10K |
| 2025-06-02 | LUNG | Pulmonx Corp | S — Open-market sale | 2.1K | $3.13 | $7K |
| 2025-06-02 | LUNG | Pulmonx Corp | S — Open-market sale | 3.6K | $3.13 | $11K |
| 2025-06-02 | LUNG | Pulmonx Corp | S — Open-market sale | 943 | $3.13 | $3K |
| 2025-06-02 | LUNG | Pulmonx Corp | S — Open-market sale | 535 | $3.14 | $2K |
| 2024-12-04 | LUNG | Pulmonx Corp | S — Open-market sale | 1.6K | $6.18 | $10K |
| 2024-12-04 | LUNG | Pulmonx Corp | S — Open-market sale | 2.8K | $6.19 | $17K |
David Aaron Lehman is the General Counsel at Pulmonx Corp, a medical technology company specializing in treatments for severe emphysema. He has been involved in the company's legal affairs, contributing to its operations in the healthcare sector.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 21 open-market sales ($122K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Lehman David Aaron profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.